Guidelines for the diagnosis and treatment of malignant pleural mesothelioma - PMC Back to
Top Skip to main content NIH NLM Logo Access keys NCBI Homepage MyNCBI Homepage …

The detection of neoplastic invasion remains the linchpin for a clear diagnosis of malignant
mesothelioma. Cytology-only diagnosis of epithelioid mesothelioma on aspirated effusion …

Incidence of malignant pleural mesothelioma (MPM) is generally higher in males than
females and is attributed to historical differences in exposures with world-standardised …

Purpose To provide evidence-based recommendations to practicing physicians and others
on the management of malignant pleural mesothelioma. Methods ASCO convened an …

The European Respiratory Society (ERS)/European Society of Thoracic Surgeons
(ESTS)/European Association for Cardio-Thoracic Surgery (EACTS)/European Society for …

Refer all patients with a chest X-ray suggestive of MPM urgently (via the 2-week wait
suspected cancer pathway in England and Wales). Consider referral for further investigation …

Introduction Chronic inflammation plays a key role in the pathogenesis of malignant pleural
mesothelioma (MPM) as a result of asbestos exposure. Biomarkers of systemic inflammation …

Abstract The European Respiratory Society (ERS)/European Society of Thoracic Surgeons
(ESTS)/European Association for Cardio-Thoracic Surgery (EACTS)/European Society for …

Abstract Malignant Pleural Mesothelioma (MPM) remains a relevant public health issue, and
asbestos exposure is the most relevant risk factor. The incidence has considerably and …

The 2021 WHO Classification of Tumors of the Pleura has introduced significant changes in
mesothelioma codification beyond the three current histological subtypes—epithelioid …